Evidence map›Paper›PMID 38205268›Full record

ArticleBioinformatics advances2024

Seq2Phase: language model-based accurate prediction of client proteins in liquid-liquid phase separation.

Kazuki Miyata, Wataru Iwasaki

Open access · goldAbstract read
In one paragraph

Article in Bioinformatics advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kazuki MiyataDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.
Wataru IwasakiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.ORCID https://orcid.org/0000-0002-9169-9245
The University of Tokyo · JPUbe Frontier University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Liquid-liquid phase separation (LLPS) enables compartmentalization in cells without biological membranes. LLPS plays essential roles in membraneless organelles such as nucleoli and p-bodies, helps regulate cellular physiology, and is linked to amyloid formation. Two types of proteins, scaffolds and clients, are involved in LLPS. However, computational methods for predicting LLPS client proteins from amino-acid sequences remain underdeveloped. Results: Here, we present Seq2Phase, an accurate predictor of LLPS client proteins. Information-rich features are extracted from amino-acid sequences by a deep-learning technique, Transformer, and fed into supervised machine learning. Predicted client proteins contained known LLPS regulators and showed localization enrichment into membraneless organelles, confirming the validity of the prediction. Feature analysis revealed that scaffolds and clients have different sequence properties and that textbook knowledge of LLPS-related proteins is biased and incomplete. Seq2Phase achieved high accuracies across human, mouse, yeast, and plant, showing that the method is not overfitted to specific species and has broad applicability. We predict that more than hundreds or thousands of LLPS client proteins remain undiscovered in each species and that Seq2Phase will advance our understanding of still enigmatic molecular and physiological bases of LLPS as well as its roles in disease. Availability and implementation: The software codes in Python underlying this article are available at https://github.com/IwasakiLab/Seq2Phase.

Identifiers

PMID38205268
PMCPMC10777356
OpenAlexW4390096274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.